CS Medica A/S (NGM: CSMED)

Market Cap	106.13M
Revenue (ttm)	12.84M
Net Income (ttm)	-14.64M
Shares Out	13.81M
EPS (ttm)	-0.85
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	209,700
Open	6.53
Previous Close	6.57
Day's Range	6.36 - 7.72
52-Week Range	3.07 - 17.99
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 14, 2024

About CS Medica

CS MEDICA A/S develops, manufactures, and commercializes over the counter medical products containing cannabinoids for the treatment of psoriasis and arthritis. It offers gels for psoriasis, arthritis, protective nasal, and wound healing; and CBD anti-hair loss serum, as well as sleep nasal sprays and pain patches. The company primarily offers its products under the CANNASEN brand name. It also acts as a distributor of other cosmeceuticals and natural cosmetics in the Nordic region. The company was incorporated in 2011 and is based in Copenhage...

• Industry: Pharmaceutical Preparations
• Founded: 2011
• Employees: 9
• Stock Exchange: Nordic Growth Market
• Ticker Symbol: CSMED

Financial Performance

In 2024, CS Medica's revenue was 8.46 million, an increase of 692.80% compared to the previous year's 1.07 million. Losses were -9.65 million, -33.50% less than in 2023.

Financial numbers in DKK